Publication database

IB financing as an investment and policy tool is a nascent tool with a promising but inconsistent track record in generating positive financial, economic, social, and environmental returns. Given the nexus binding exclusion, poverty, inequality, and resource consumption, this report argues that IB financing matters.

This report provides case studies and lessons learned from seven Asian countries in five areas of innovative financing for development. Such innovative financing for development would benefit inclusive businesses as a new source of funding.

“Can health microinsurance (HMI) schemes achieve sustainability?” As with many seemingly simple questions, there is no simple answer. The answer to this question is of interest to a variety of parties. Insurance providers seek to understand if there is a viable business case for offering an HMI product. Health-care providers and pharmaceutical companies are interested in whether or not HMI can be a means for broadening coverage. Donors and other funding organizations want to know if HMI is a viable investment as a means to improve health-care access, health outcomes and financial protection for the low-income population. Governments consider how to use HMI schemes as a step towards universal health coverage.

This paper seeks to answer this simple yet crucial question based on the experiences of five schemes in South Asia.